NASDAQ:BMRN Investor Notice: Lawsuit Alleges Misleading Statements by BioMarin Pharmaceutical Inc.
November 18, 2021 at 13:00 PM EST
San Diego, CA -- (SBWIRE) -- 11/18/2021 -- An investor, who purchased NASDAQ:BMRN shares, filed a lawsuit against BioMarin Pharmaceutical Inc. over alleged violations of Federal Securities Laws.
